Free Trial
NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Price, News & Analysis

Aveanna Healthcare logo
$8.08 -0.15 (-1.82%)
Closing price 04:00 PM Eastern
Extended Trading
$8.10 +0.02 (+0.25%)
As of 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Aveanna Healthcare Stock (NASDAQ:AVAH)

Advanced

Key Stats

Today's Range
$7.99
$8.35
50-Day Range
$3.74
$8.44
52-Week Range
$3.67
$8.54
Volume
1.00 million shs
Average Volume
1.17 million shs
Market Capitalization
$1.69 billion
P/E Ratio
101.00
Dividend Yield
N/A
Price Target
$7.50
Consensus Rating
Moderate Buy

Company Overview

Aveanna Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

AVAH MarketRank™: 

Aveanna Healthcare scored higher than 25% of companies evaluated by MarketBeat, and ranked 856th out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aveanna Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Downside Risk

    Aveanna Healthcare has a consensus price target of $7.50, representing about 7.2% downside from its current price of $8.08.

  • Amount of Analyst Coverage

    Aveanna Healthcare has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Aveanna Healthcare's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aveanna Healthcare is 101.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 268.10.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aveanna Healthcare is 101.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 57.40.

  • Read more about Aveanna Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    9.97% of the float of Aveanna Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Aveanna Healthcare has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Aveanna Healthcare has recently increased by 115.94%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aveanna Healthcare does not currently pay a dividend.

  • Dividend Growth

    Aveanna Healthcare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.97% of the float of Aveanna Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Aveanna Healthcare has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Aveanna Healthcare has recently increased by 115.94%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Aveanna Healthcare has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Aveanna Healthcare this week, compared to 3 articles on an average week.
  • Search Interest

    5 people have searched for AVAH on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aveanna Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.80% of the stock of Aveanna Healthcare is held by insiders.

  • Percentage Held by Institutions

    87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aveanna Healthcare's insider trading history.
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVAH Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
See More Headlines

AVAH Stock Analysis - Frequently Asked Questions

Aveanna Healthcare's stock was trading at $4.57 at the beginning of the year. Since then, AVAH shares have increased by 76.8% and is now trading at $8.08.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) released its quarterly earnings data on Thursday, November, 7th. The company reported $0.02 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.03. The company had revenue of $509.02 million for the quarter, compared to analyst estimates of $495.80 million. Aveanna Healthcare had a net margin of 0.85% and a negative trailing twelve-month return on equity of 54.56%.
Read the conference call transcript
.

Aveanna Healthcare (AVAH) raised $478 million in an IPO on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Top institutional shareholders of Aveanna Healthcare include J.H. Whitney Equity Partners VII LLC (23.54%), Summit Partners L P (4.95%), King Street Capital Management L.P. (2.18%) and Geode Capital Management LLC (0.72%). Insiders that own company stock include Robert M Williams Jr, Paul R Vigano, JH Whitney Equity Partners V, Matthew Buckhalter, Patrick A Cunningham, Deborah Stewart and Victor F Ganzi.
View institutional ownership trends
.

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aveanna Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
11/07/2024
Today
9/17/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:AVAH
CIK
1832332
Fax
N/A
Employees
33,500
Year Founded
N/A

Price Target and Rating

High Price Target
$9.50
Low Price Target
$5.00
Potential Upside/Downside
-8.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.08
Trailing P/E Ratio
102.06
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.93 million
Net Margins
0.85%
Pretax Margin
2.47%
Return on Equity
-54.56%
Return on Assets
3.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.09
Quick Ratio
1.09

Sales & Book Value

Annual Sales
$2.18 billion
Price / Sales
0.78
Cash Flow
$0.16 per share
Price / Cash Flow
51.17
Book Value
($0.64) per share
Price / Book
-12.78

Miscellaneous

Outstanding Shares
208,896,000
Free Float
194,273,000
Market Cap
$1.71 billion
Optionable
Optionable
Beta
2.04
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:AVAH) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners